Clinical trial
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 is registered in ClinicalTrials.gov with Astellas Pharma China, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
- Lead sponsor
- Astellas Pharma China, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- August 31, 2015
- Enrollment
- 2,555 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.